4219.0: Tuesday, November 14, 2000 - 2:58 PM

Abstract #11022

Use of Apligraf in the management of chronic venous stasis and diabetic ulcerations

Neil L. Horsley, DPM, Department of Orthopedics, William M. Scholl College of Podiatric Medicine, 1001 N. Dearborn, Chicago, IL 60610, 312-280-2880, hfac@aol.com

Apligraf (R) is currently in use and is approved for use for the treatment of Chronic Venous Stasis Ulcerations. This presentation will discuss several cases that represent long-standing chronic ulcerations for which Apligraf (R) is used to augment wound closure. The biochemistry, anatomy and indications for use of Apligraf (R) will be discussed. Wound management with antibiotics status post use of Apligraf (R). How to prevent wound colonisation with local bacterial flora. We will discuss the theory and essentials of wound compression dressings will show why these types of dressings provide maximum benefit. Studies and actual clinical applications demonstrate successful wound closures with Apligraf (R) use.

Learning Objectives: 1. Define criterion for establishing a recipient for bilaminate graft application 2. Describe procedure for proper application of Apligraf 3. Recognize signs of early complications with graft take 4. Evaluate patient progress and treat appropriately for maximal outcome

Keywords: Chronic Diseases, Diabetes

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: Novartis - Apligraf (R)
I have a significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
Relationship: Member of Speakers Bureau

The 128th Annual Meeting of APHA